Development and evaluation of a multiplex serodiagnostic bead assay (BurkPx) for accurate melioidosis diagnosis
PLOS Neglected Tropical Diseases · 2023
DOI: 10.1371/journal.pntd.0011072 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Erik W Settles und 18 weiteren Autor:innen. Beteiligte Einrichtung: The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America. Hauptthemen laut MEDLINE: Melioidosis, Burkholderia pseudomallei. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Defense Threat Reduction Agency, Arizona Technology and Research Initiative Fund, Australian National Health and Medical Research Council.
Abstract (Originalsprache)
Burkholderia pseudomallei , the causative agent of melioidosis, is a gram-negative soil bacterium well recognized in Southeast Asia and northern Australia. However, wider and expanding global distribution of B . pseudomallei has been elucidated. Early diagnosis is critical for commencing the specific therapy required to optimize outcome. Serological testing using the indirect hemagglutination (IHA) antibody assay has long been used to augment diagnosis of melioidosis and to monitor progress. However, cross reactivity and prior exposure may complicate the diagnosis of current clinical disease (melioidosis). The goal of our study was to develop and initially evaluate a serology assay (BurkPx) that capitalized upon host response to multiple antigens. Antigens were selected from previous studies for expression/purification and conjugation to microspheres for multiantigen analysis. Selected serum samples from non-melioidosis controls and serial samples from culture-confirmed melioidosis patients were used to characterize the diagnostic power of individual and combined antigens at two times post admission. Multiple variable models were developed to evaluate multivariate antigen reactivity, identify important antigens, and determine sensitivity and specificity for the diagnosis of melioidosis. The final multiplex assay had a diagnostic sensitivity of 90% and specificity of 93%, which was superior to any single antigen in side-by-side comparisons. The sensitivity of the assay started at >85% for the initial serum sample after admission and increased to 94% 21 days later. Weighting antigen contribution to each model indicated that certain antigen contributed to diagnosis more than others, which suggests that the number of antigens in the assay can be decreased. In summation, the BurkPx assay can facilitate the diagnosis of melioidosis and potentially improve on currently available serology assays. Further evaluation is now required in both melioidosis-endemic and non-endemic settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, United States of America.
- Department of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, United States of America.
- Department of Mathematics and Statistics, Northern Arizona University, Flagstaff, Arizona, United States of America.
- Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
- Infectious Diseases Department and Northern Territory Medical Program, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
ORCID-Profile: Erik W Settles, Paul Keim
Förderung
- Defense Threat Reduction Agency
- Arizona Technology and Research Initiative Fund
- Australian National Health and Medical Research Council
Zitieren
APA
Settles, E. W., Sonderegger, D., Shannon, A. B., Celona, K. R., Lederer, R., Yi, J., Seavey, C., Headley, K., Mbegbu, M., Harvey, M., Keener, M., Allender, C., Hornstra, H., Monroy, F. P., Woerle, C., Theobald, V., Mayo, M., Currie, B. J., & Keim, P. (2023). Development and evaluation of a multiplex serodiagnostic bead assay (BurkPx) for accurate melioidosis diagnosis. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011072
Vancouver
Settles EW, Sonderegger D, Shannon AB, Celona KR, Lederer R, Yi J, et al. Development and evaluation of a multiplex serodiagnostic bead assay (BurkPx) for accurate melioidosis diagnosis. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011072
BibTeX
@article{Settles2023,
author = {Settles, Erik W and Sonderegger, Derek and Shannon, Austin B and Celona, Kimberly R and Lederer, Rachel and Yi, Jinhee and Seavey, Courtney and Headley, Kyle and Mbegbu, Mimi and Harvey, Maxx and Keener, Mitch and Allender, Chris and Hornstra, Heidie and Monroy, Fernando P and Woerle, Celeste and Theobald, Vanessa and Mayo, Mark and Currie, Bart J and Keim, Paul},
title = {Development and evaluation of a multiplex serodiagnostic bead assay (BurkPx) for accurate melioidosis diagnosis},
journal = {PLOS Neglected Tropical Diseases},
year = {2023},
doi = {10.1371/journal.pntd.0011072}
}
EUVIMED